Product Description
The global orthopedic growth factor market was valued at $1.05 billion in 2024. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $1.2 billion.
The full report suite on the global orthopedic growth factor market categorizes growth factors into four indication types: cervical disc degeneration, tibial fractures, spine and ankle and hindfoot fusion.
This report includes data for 65 countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2021
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET INSIGHTS
The orthopedic growth factor market experienced a notable decline in sales due to the COVID-19 pandemic. The primary driver was the widespread cancellation and postponement of elective surgeries, which significantly disrupted the industry’s ecosystem. While this downturn was temporary, the impact in 2020 was substantial, with many companies incurring unprecedented losses. However, the market demonstrated resilience and managed to recover notably by 2022, returning to its trajectory of steady growth.
GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET SHARE INSIGHTS
- Medtronic was the leader of the orthopedic growth factor market. Medtronic’s INFUSE® product remains the gold standard for spinal fusion therapies.
- Cerapedics was the second-leading competitor in the orthopedic growth factor market in 2024. The company competes in the market with its i-Factor™, which recently received expanded FDA approval for single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring, or in conjunction with a polyetheretherketone (PEEK), titanium alloy or PEEK/titanium fusion interbody device to use in the cervical spine, and with supplemental anterior plate fixation.
- Stryker held the third-leading position in the orthopedic growth factor market by offering the AUGMENT® product line, as the first and only U.S. Food and Drug Administration (FDA)-approved alternative to autograft in hindfoot and ankle arthrodesis.
GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET SEGMENTATION SUMMARY
- Cervical Disc Degeneration Market
- Tibial Fracture Market
- Spine
- Ankle & Hindfoot Fusion
GLOBAL RESEARCH SCOPE
Report Attribute | Details |
---|---|
Regions | North America(Canada, United States) Latin America(Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe(Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific(Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa(Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2024 |
Forecast | 2025-2031 |
Historical Data | 2021-2023 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |